Finaves S.C.R.

Portfolio · 1

Gerium Medical

Noninvasive Bilirubin Measurement Device

2 rounds Latest: 2011-12

Investment activity

1 portfolio exit on record.

Q&A

What is Finaves S.C.R.'s primary sector focus?

Finaves S.C.R. has shown a concentration in the Health Tech & Life Sciences sector, with all its recorded portfolio companies and exits falling within this area.

Can you name a notable exit for Finaves S.C.R.?

Finaves S.C.R. exited Gerium Medical in June 2015 when it was acquired by Mennen Medical group.

What type of companies does Finaves S.C.R. typically invest in?

Finaves S.C.R. has invested in companies like Gerium Medical, which develops B2B non-invasive medical devices.

When was Finaves S.C.R.'s most recent exit?

Finaves S.C.R.'s most recent recorded exit was in June 2015, with the acquisition of Gerium Medical.

What is the funding stage focus for Finaves S.C.R.?

Finaves S.C.R. has participated in both A Round and B Round funding stages.

When did Finaves S.C.R. make its first recorded investment?

Finaves S.C.R. made its first recorded investment in August 2011.